Recommendations for management of patients with neuroendocrine liver metastases
Top Cited Papers
- 1 January 2014
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 15 (1), e8-e21
- https://doi.org/10.1016/s1470-2045(13)70362-0
Abstract
No abstract availableThis publication has 82 references indexed in Scilit:
- The Identification of Gut Neuroendocrine Tumor Disease by Multiple Synchronous Transcript Analysis in BloodPLOS ONE, 2013
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)European Journal of Nuclear Medicine and Molecular Imaging, 2011
- DAXX / ATRX , MEN1 , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine TumorsScience, 2011
- Long-term survival after surgical management of neuroendocrine hepatic metastasesHPB, 2010
- MicroRNA expression in ileal carcinoid tumors: downregulation of microRNA-133a with tumor progressionLaboratory Investigation, 2010
- Hepatic Metastases From Neuroendocrine Tumors With a “Thin Slice” Pathological ExaminationAnnals of Surgery, 2010
- Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liverEuropean Journal of Surgical Oncology, 2009
- Hepatic Neuroendocrine Metastases: Chemo- or Bland Embolization?Journal of Gastrointestinal Surgery, 2008
- Gastroenteropancreatic neuroendocrine tumoursThe Lancet Oncology, 2008